4 September 2009: Two new antibodies found by scientists in blood from a donor who was infected with the virus in Africa.
Researchers have discovered two new antibodies that could potentially be used to develop an HIV vaccine.
The study, published in the journal Science, has uncovered two antibodies called PG9 and PG16. Antibodies are proteins that are part of the immune system. They act as a defence mechanism to prevent viruses causing infections in the body.
The antibodies were found by scientists in blood from a donor who was infected with the virus in Africa. A small number of people with HIV react to the infection and produce these antibodies.
The antibodies are able to bind to an HIV-1 protein and deactivate the virus, preventing it from causing further infection. When compared to antibodies previously found, PG9 and PG16 were found to be much more effective against the virus.
HIV is difficult to target because its outer surface changes so it can ‘hide’ from the immune system. If a vaccine containing the antibodies could be developed, it could be used to prevent HIV-1 infection if a person is exposed to the virus.
Dr Sneh Khemka, medical director for Bupa International, said: “This research offers future hope for what has so far been an elusive hunt for an HIV vaccine. These are the first new antibodies to be found in a decade, which is a significant discovery. They seem more potent and work on a broader spectrum than other potential HIV vaccines, offering much hope for the future.”
To discuss your needs, please call us on: